As consumer awareness of nutritional needs across different life stages and lifestyles has increased, the bar has been raised for nutraceutical manufacturers to deliver evidence-based, high-quality health solutions.
Scientific substantiation, regulatory compliance, sustainable sourcing and manufacturing excellence are no longer differentiators; they are baseline expectations.
A dedicated platform for a fast-evolving market
Driven by innovation in functional ingredients, novel delivery systems, personalised nutrition and clinical validation, the nutraceutical market continues to evolve.
In response, Making Nutraceuticals provides a focused meeting point for professionals spanning R&D, functional ingredients, regulatory affairs, formulation, brand strategy, contract manufacturing and supply chain management.
Combining a specialist exhibition, high-level conference programme and industry awards, Making Nutraceuticals delivers strategic insight alongside practical solutions — supporting innovation from concept through to commercialisation.
The free-to-attend conference programme features leading sector organisations, including the Health Food Manufacturers’ Association, the Council for Responsible Nutrition and cutting-edge research from the Centre for Nutraceuticals.
Unlocking synergies with pharmaceuticals
Colocated with the established Making Pharmaceuticals and Distributing Pharmaceuticals exhibitions, the event reflects the growing alignment between the sectors.
From GMP compliance and quality systems to manufacturing technologies, packaging innovation and supply chain resilience, the divide between pharmaceutical and nutraceutical production continues to narrow.
Visitors will have access to a total of nine free-of-charge conference streams throughout the combined events, including a dedicated nutraceutical theatre alongside sessions covering AI and digitalisation, regulatory strategy, contamination control, ingredient innovation, new research, sustainability, outsourcing and supply chain optimisation.
A poster presentation area will showcase the very latest in nutraceutical and pharmaceutical research.
Evidence-led innovation
Scientific substantiation underpins the nutraceutical programme. Across two days, the specialist nutraceutical stream explores the technical, regulatory and commercial considerations involved in bringing credible, compliant products to market.
Practical sessions such as Food Supplements 101, delivered by the Council for Responsible Nutrition (CRN), and GMP – Its Importance in Manufacturing Quality Food Supplements, and How EU Food Regulations are Affecting the UK Supplement Market, by the Health Food Manufacturers’ Association, sit alongside expert insight from MHRA’s Borderline team.
Key themes include medicinal versus health claims, sustainable packaging, product development challenges and the realities of outsourcing UK contract manufacturing.
Women in Nutraceuticals (WIN) and the Pharmaceutical Special Interest Group of the Ethical Medicines Industry Group (EMIG) are holding a workshop on Formulating Ethical, Evidence-Based Solutions for Women’s Health, and there is a WIN and EMIG Networking breakfast, to which all attendees are invited.
Emerging science also features strongly. Sessions examine protein-driven appetite regulation, oxidative stress and inflammation pathways, and advanced collagen applications, including potential interaction with GLP-1 metabolism.
With gut health continuing to dominate consumer interest, clinically substantiated probiotic strains are explored through a lifespan lens, whereas bioavailability challenges are addressed through next-generation delivery technologies and mineral transport science.
The programme reflects a sector that is not only expanding but maturing in scientific depth and regulatory rigour.
From ingredient innovation to finished product
The exhibition spans the full nutraceutical value chain — from raw materials to finished dosage forms. Leading ingredient suppliers, formulation specialists, contract manufacturers, packaging experts and regulatory advisers will attend, including Azelis, IMCD UK, JRS, Rousselot, Safic-Alcan, Biogrund and Select Botanical.
Industry bodies such as HFMA, CRN and MHRA will also be present, offering rare direct access to regulatory and sector-specific expertise.
For brands, manufacturers and product developers, the event provides a platform to discover new ingredients, evaluate technologies and build strategic partnerships.
Shaping the future of natural health
Beyond product innovation, Making Nutraceuticals addresses the broader responsibilities shaping the sector’s future. Sustainability, ethical formulation, women’s health innovation and supply chain resilience form part of the wider conversation.
For businesses focused on formulation excellence, regulatory confidence and sustainable commercial growth, Making Nutraceuticals is where the sector’s next chapter begins.
“Making Nutraceuticals has been created to bring together the professionals shaping the future of the sector, from ingredient innovation through to compliant manufacturing.”
“By colocating it with Making Pharmaceuticals, we’re creating a space in which the nutraceutical and pharmaceutical communities can connect, collaborate and spark new ideas that support healthier futures,” commented Jay Stacy, Exhibition Director.
For more information
Register for your free place at www.makingnutra.com and join the UK’s dedicated event for nutraceutical innovation.
